Waterman LA, Polsky S, Akturk HK, Stewart B, Karami AJ, Taylor K, Cobry EC. Substance Use, Sexual Activity Prevalence, and Knowledge Gaps in Young Adults with Type 1 Diabetes in a Pediatric Clinic. Diabetes Metab Syndr Obes. 2026;19:590267. PubMed PMID: 41756709
Waterman LA, Nadeau KJ; Akturk HK, Polsky S, Karami AJ, Cobry E. “Glucagon-like Peptide-1 Receptor Agonist (GLP-1RA) or GLP-1RA/Glucose-Dependent Insulinotropic Polypeptide RA (GLP-1/GIPRA) Effects in Youth/Young Adults (Y/YA) with Type 1 Diabetes and Characteristics of Non-Responders.” e-Poster presentation at American Diabetes Association (ADA) Scientific Session, June 2026
Cobry EC, Waterman L, Mason E, Cengiz D, Akturk HK. “Glycemic Goal Knowledge Among Adolescents with Type 1 Diabetes: Gaps and Demographic Difference.” Accepted as ISPAD 2026 oral presentation
Waterman, L, Polsky S, Stewart B, Karami AJ, Taylor K, Cobry E. "Substance Use in Young Adults with Type 1 Diabetes (T1D) in a Pediatric Clinic," e-Poster presentation at American Diabetes Association (ADA) Scientific Session, June 2025
Waterman L, Snell-Bergeon JK, Polsky S. "Timing of Adult Transition on Outcomes for Pregnant Young Adults with Type 1 Diabetes." Poster presentation at American Diabetes Association (ADA) Scientific Session, June 2025
Waterman L, Boranian E, Cobry E. "Development of Transition Curriculum from Patient Identified Topics." Planned oral presentation at the T1D Exchange QI Collaborative, Nov 2025
Waterman L, Stewart B, Karami A, Taylor K, Cobry E. "Self-identified areas of interest for pediatric patients with type 1 diabetes prior to adult transition." Planned e-poster presentation at the International Society for Pediatric and Adolescent Diabetes (ISPAD) 2025 conference in Montreal, Canada, Nov 2025.
Waterman L, Sakamoto C, Polsky S, Berget C, Cobry E. “Glycemic and psychosocial outcomes with automated
insulin delivery systems in adolescents and young adults with type 1 diabetes over 12 months.” International
Society for Pediatric and Adolescent Diabetes (ISPAD), October 2024
Waterman LA, Cobry EC, Sakamoto C, Thompson T, Polsky S, Berrian K, Alonso GT. “Insulin Cost and Rationing
in the Pediatric Type 1 Diabetes Population.” T1D Exchange-QI Collaborative, Planned November 2024
Mianowska B, Hauser E, Waterman L, Zineb I, Besancon S, Sabolic LLG, Smart C, Kim JH, Kadr M, Ferreira S,
Rigamonti A, Henderson M, Szadkowska A. “Time trend of BMI-SDS before, during and after the COVID-19
pandemic: data from the SWEEET Diabetes Registry.” International Society for Pediatric and Adolescent Diabetes
(ISPAD), October 2024
LA Waterman et al. Insulin Insecurity and Its Subsequent Impact on Emerging Adults and Families of Children With Type 1 Diabetes. Diabetes Spectrum
Aturk HK, Waterman L, Cobry E. "Revolutionizing Diabetes Care: From Tech to Therapeutics." Diabetes, Metabolic Syndrome, and Obesity.
Waterman LA, Stein A, K Nadeau, EC Cobry. “Glucagon-like peptide-1 (GLP-1RA) and GLP-1/Glucose-dependent insulinotropic polypeptide receptor agonist (GLP1/GIP-RA) effectiveness in adolescents and young adults (AYA) with type 1 diabetes by insulin administration method.” Submitted ATTD 2027
McLean SA, Klein MP, Waterman LA, Cengiz D, Slade J, Helle M, Polsky s. “Evaluating the effects of GLP-1 receptor agonists on hepatic function in patients with type 1 diabetes.” Submitted to ATTD 2027
Waterman LA, Cobry EC, Akturk HK, Polsky S, Karami AJ, Stein A, Nadeau KJ. “Effectiveness of Glucagon-like Peptide 1 Receptor Agonist Therapy in Adolescents and Young Adults with Type 1 Diabetes and the Impact of the Timing of Overweight or Obesity development.”
Akturk HK, Mason E, Cengiz D, Waterman L, Cobry EC. "Understanding the Ambulatory Glucose Profile: Knowledge of Glycemic Targets Among People with Type 1 Diabetes and Their Caregivers."